Phase II study on radiofrequency ablation in early breast cancer

Phase II study on radiofrequency ablation in early breast cancer - Radiofrequency ablation in early breast cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020805

Enrollment

Registered

2016-01-30

Start date

2009-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

RFA with LeVeen needle electrode and generator Insertion into the referent tumor under ultrasound guidance Ablation completed twice until so-called roll off with increase of watts by generator

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: T1 and sentinel node-negative breast cancer (BC) patients were eligible

Exclusion criteria

Exclusion criteria: BC with diffuse calcification or extensive intraductal component (EIC) was excluded.

Design outcomes

Primary

Measure	Time frame
Breast deformity after RFA	—

Secondary

Measure	Time frame
adverse events QoL ipsilateral breast tumor recurrence	—

Countries

Japan

Contacts

Public ContactKazumi Takano

School of Medicine Kyorin University Department of Breast Surgery

k-takano@ks.kyorin-u.ac.jp0422-47-6273

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026